marietatheod

[Hans-Joachim Anders @hjanders_hans]

Now open acces in @NDTsocial

FINE-ONE, more to come: moving beyond ACEis and ARBs in T1DM with kidney disease?

🧐After >30Y without major therapeutic advances FIND-One is the first of many RTCs to come about how to prevent progression of CKD in T1DM

▶️https://t.co/i6Tt5bC9ks

[YNP of ERA @ynptweets]

Meet & Greet was a success! Thanks to all participants! 🎉

#ERA25 @ERAkidney

[Roser Torra @torra_roser]

@aortznfr presenting the ABCDE (Albuminuria, Blood pressure, Cholesterol, Diabetes, eGFR) campaign from @ERAkidney at @EKHA_EU @EuParlament early diagnosis saves kidneys saves lives #kidneyforum2025 🇪🇺🇪🇺🇪🇺

[JASN_News @JASN_News]

Torsemide is proposed to have clinically important pharmacokinetic and pharmacodynamic advantages over furosemide. This study found no meaningful pharmacokinetic/pharmacodynamic advantages for torsemide versus furosemide. https://t.co/JCyaecBiAS
@ClevelandClinic
@CleClinicMD
@fperrywilson
@dhekidney

[YNP of ERA @ynptweets]

🔥 Our snapshot summary on a survey study on what patients with CKD actually want to know!

https://t.co/WBiS5mHhuB

Jet Milders is the YNP author.

Prepared by @DocL_Floyd.

@ERAkidney @CKJsocial

[YNP of ERA @ynptweets]

Our board had a meeting at @ERAkidney headquarters in Parma!

Two days of great discussions on our current and future activities!

[ASN Publications @asnpublications]

EMPA-KIDNEY expanded the CKD population that may benefit from SGLT2 inhibitors in terms of eGFR and UACR. In patients meeting the enrollment criteria for the EMPA-KIDNEY trial, the addition of empagliflozin to the standard treatment of CKD was as cost-effective for patients with albuminuria but not for those without it in the Japanese healthcare system. https://t.co/dRE4xvR1oa

[YNP of ERA @ynptweets]

Another @CKJsocial In Context was published!

@kumru_gizem and @KristaLentine on hypertension in living kidney donors, the study by @AmitXGarg and colleagues. @JAMA_current

@ERAkidney

https://t.co/BU87ckCnCK

[NDT @NDTsocial]

Proximal versus distal diuretics in congestive heart failure

🆓https://t.co/1zv1iEl5Bc

[Joel M. Topf, MD FACP @kidney_boy]

Ignore eGFR
Ignore Creatinine
Start dialysis when the patient is symptomatic

We learned this with IDEAL in 2010 (https://t.co/CLw6bC5sdI) and it is still true today (or at least on August 20th in the Annals, https://t.co/CCinQiI2Dj)

[ERA - European Renal Association @ERAkidney]

📢 Join us for the 3rd @EspnYpnn – @ynptweets joint e-seminar : *#IgA #nephropathy, from #childhood to #adulthood including transition* with expert speakers and a patient perspective.
📅 September 6, 2024, 4 PM (CEST)
Register now 👉 https://t.co/CRClftXrdR

[Kidney International @Kidney_Int]

Deciphering the kidney hemodynamic effects of #SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes

https://t.co/bYbGv22V4z

Original article:
https://t.co/Fuk5dIXyGq

@UWDeptMedicine @medcmuofficial
#KICommentary #diabetes

[EJHF Editor-in-Chief @EJHFEiC]

Decongestion in #AHF : Is it time to change #diuretic-centred paradigm?

This fantastic review discusses the latest in decongestive therapies for #HeartFailure
@JanBiegus
@MarcoMetra @ESC_Journals

https://t.co/WNEwkBDZ3O

@HanCardiomd @AmrAbdin10 @GiuseppeGalati_

[CKJ @CKJsocial]

Point-of-care ultrasound training in nephrology:
a position statement by the International Alliance for POCUS in Nephrology

🔓https://t.co/g8RKpzHoxL

This statement aims to guide nephrologists in harnessing the diagnostic power of POCUS responsibly and effectively

[YNP of ERA @ynptweets]

🤩 New snapshot summary on pneumococcal vaccination in patients with reduced kidney function!

https://t.co/ABzZYbBbpp

Dustin Le is the YNP author.

Prepared by @DocL_Floyd.

@ERAkidney @CKJsocial

[YNP of ERA @ynptweets]

Snapshot summary by @DocL_Floyd on kidney phosphate wasting in polycystic kidney disease. 😎

https://t.co/sC4RI0wg82

Mahdi Salih is the YNP author.

@ERAkidney @NDTsocial @hjanders_hans

[NDT @NDTsocial]

👍Selected from July issue:

Uromodulin biology

🔓https://t.co/bAN2HDpvS8

This Review presents an updated overview of the uromodulin's biology and its various roles, and focuses on the interaction between uromodulin and sodium-sensitive hypertension.

[Brendon Neuen @brendonneuen]

"Are we witnessing a convergence of GDMT for heart failure and CKD?"

Here is my plenary talk from the recent @goKDIGO Controversies Conference on Kidney Disease and Heart Failure

My answer was probably yes, with some important caveats

https://t.co/Tzv9GrWuZO

[Jasmine Sethi @JasmineNephro]

📈🫘How to set electrolyte composition in dialysis

https://t.co/Xg7pZmXAz4

@CKJsocial

[ASN Publications @asnpublications]

Blood purification by dialysis is a nephrology cornerstone. This Perspective provides an update on current knowledge on hemoadsorption and describes its current use and research agenda for the future https://t.co/gU1ZrsdOZb

@ForniLuiG